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Abstract:  To understand and characterize the pathogenic mechanisms of inflammatory 
bowel disease, dextran sulfate sodium (DSS) has been used to induce acute and chronic 
colitis in animal models by causing intestinal epithelium damage. The mechanism of action 
of DSS in producing this outcome is not well understood. In an effort to understand how 
DSS might impact epithelial cell metabolism, we studied the intestinal epithelial cell line 
Caco-2 incubated with 1% DSS over 56 hours using 
1H NMR spectroscopy. We observed 
no  difference  in  cell  viability  as  compared  to  control  cultures,  and  an  approximately  
1.5-fold increase in IL-6 production upon incubation with 1% DSS. The effect on Caco-2 
cell metabolism as measured through changes in the concentration of metabolites in the 
cell supernatant included a three-fold decrease in the concentration of alanine. Given that 
the concentrations of other amino acids in the cell culture supernatant were not different 
between  treated  and  control  cultures  over  56  hours  suggest  that  DSS  inhibits  alanine 
synthesis,  specifically  alanine  aminotransferase,  without  affecting  other  key  metabolic 
pathways.  The  importance  of  alanine  aminotransferase  in  inflammatory  bowel  disease  
is discussed. 
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1. Introduction 
Crohn’s disease (CD) and ulcerative colitis (UC), both inflammatory bowel diseases (IBD), involve 
chronic  inflammation  of  the  gastrointestinal  tract.  The  etiology  and  mechanisms  of  IBD  remain 
unclear, but it is generally agreed to be a complex interplay between the immune system, genetics, and 
environmental factors. To aid in the understanding of the pathogenesis of the disease, dextran sulfate 
sodium  (DSS)  has  been  used  to  induce  colitis  in  experimental  animal  models  [1,2].  DSS  is  a  
water-soluble polymer of glucose containing up to 20% sulfur with molecular weights ranging from 
5,000 to 1.4 million Da. DSS is poorly absorbed after oral administration of enteric coated tablets, and 
no evidence of systemic absorption has been observed in humans [3]. Depending on the concentration, 
molecular weight, sulfation, and length of exposure, oral administration of DSS to rodents has been 
shown to induce acute or chronic
 colitis that resembles UC [1,4,5]. When supplied with DSS in their 
drinking water, mice develop
 colonic mucosal inflammation with ulcerations, body weight loss,
 and 
bloody  diarrhea  that  resolves  after  DSS  removal  [4].  Chronic  inflammation  may  be  induced  by 
administration of a further three to five cycles
 of DSS [6,7]. 
Intestinal epithelium
 damage is a key feature of DSS-induced colitis, characterized
 by multi-focal 
areas of mucosal erosion, epithelial
 cell injury, and significant mucosal infiltration of neutrophils [8]. 
A  recent  study  involving  a  mouse  model  of  DSS-induced  colitis  showed  that  epithelial  apoptosis 
increased approximately five-fold, mitotic cells decreased by approximately half, and cells with cell 
cycle arrest at G0 increased two-fold in DSS treated mice as compared to control mice [9]. 
The effects of DSS have also been studied in cell-culture models. For instance, it has been shown 
that  DSS  alters  Caco-2  tight  junctions,  cell  cycle  metabolism,  as  well  as  cytokine  release  at 
concentrations ranging from 0.3% to 5% w/v [7,10]. DSS at higher molecular weights and higher 
concentrations  tended  to  have  a  greater  effect  on  cell  viability  [10].  However,  it  is  unclear  what 
metabolic changes happen to colon epithelial cells in the absence of bacteria. In the present study, we 
apply 
1H NMR-based metabolomics to study how DSS affects the extracellular metabolites of Caco-2 
cells in an effort to understand the mechanism of action of DSS on epithelial cells. 
2. Results and Discussion 
2.1. Cell Viability of Caco-2 Cells Treated with DSS Is Similar to Control 
To  determine  whether  treated  cells  were  viable  after  incubation  with  DSS,  a  trypan
 blue  dye 
exclusion assay was performed (Figure 1). At specific time points from 2 to 56 h, numbers of viable 
cells exposed to 1% DSS were compared to those of controls. No difference in cell viability was found 
over 56 h. In addition, microscopy did not reveal any significant morphological changes between 
treated and untreated Caco-2 cells. Int. J. Mol. Sci. 2011, 12                       
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Figure 1. Incubation of Caco-2 with dextran sulfate sodium (DSS) does not affect viability 
or morphological characteristics of Caco-2. (A) Numbers of viable cells were determined 
using  the  trypan
  blue  dye  exclusion  method.  Percent  viability  was  expressed  as  the 
percentage of growth compared to total cells at each time point; (B) Images of Caco-2 cells 
using microscopy at 40×  were acquired using an Olympus digital camera. Each time point 
for both treated and untreated groups represents the mean of four determinations. 
 
2.2. Interleukin-6 Level Increases with DSS Incubation 
To  determine  the  effect  of  1%  DSS  on  expression  of  interleukin-6  (IL-6),  IL-6  assays  were 
performed and compared between control and DSS-treated Caco-2 cells (Figure 2). At all timepoints, 
the concentration of IL-6 in the cell supernatant was determined to be higher for the DSS-treated cells. 
Figure 2. Secretion of IL-6 in cell culture medium by control ( ) and 1% DSS-treated ( ) 
Caco-2 cells. Supernatants were collected for each of control and DSS-treated cells at 2, 6, 
8, 10, 24, 32, and 56 hours, and IL-6 levels were measured, and averaged. Results therefore 
represent the mean of 28 determinations  SD, p = 0.00003. 
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2.3. DSS Induces Changes in 
1H NMR Spectra of Supernatant Derived from Culture of Caco-2 Cells 
To determine the effect of 1% DSS on metabolism of Caco-2 cells, 
1H NMR spectroscopy was 
performed and compared between control and DSS-treated Caco-2 cell supernatants. Representative 
spectra from control and 1% DSS-treated cells at 56 h are shown in Figure 3. The concentration of 
alanine was higher in the control culture in comparison with the DSS-treated culture. Interestingly, no 
changes in lactate were observed upon incubation with 1% DSS, however, glucose concentrations 
appeared  to  be  slightly  higher  in  DSS-treated  cells,  but  due  to  variability  between  samples,  the 
difference  was  not  significant  (Figure  4).  Ethanol  was  a  contaminant  in  all  samples,  and  its 
concentration was determined to not be significantly different between treated and untreated cells. 
Figure  3.  Representative  600  MHz 
1H  NMR  spectra  obtained  from  cell  supernatant 
extracts  from  control  and  DSS-treated  Caco-2  cells.  IS  (internal  standard)  represents 
sodium 2, 2-dimethyl-2-silapentane-5-sulfonate used as chemical shift reference. Ethanol is 
a contaminant. 
 
Comparison  of  metabolite  concentrations  in  the  cell  culture  media  between  the  control  and  
DSS-treated  Caco-2  cells  revealed  statistically  significant  higher  concentrations  of  alanine  in  the 
control culture supernatant (Figure 4), with a concentration approximately three times greater than the 
concentration of alanine in the supernatant of DSS-treated cells. In the media alone, the concentration 
of alanine is approximately 100 M. However, in both control and DSS-treated cells the concentration 
of alanine increases over time to nearly 2 mM for the control, and 600 M for the DSS-treated cells 
suggesting that alanine is exported from the cell. Interestingly, the concentration of lactate in the cell 
culture supernatant was similar between the control and DSS-treated cells. Comparison of metabolites 
imported into the Caco-2 cells (including glucose, glutamine, and pyruvate) revealed no significant 
differences  between  control  and  DSS-treated  cells  (Figure  4).  Glutamate  concentrations  were  not Int. J. Mol. Sci. 2011, 12                       
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significantly different between treated and control cells, and -ketoglutarate was undetectable in the 
cell culture supernatant. 
Figure  4.  Comparison  of  the  concentration  of  metabolites  in  control  ( ),  and  1%  
DSS-treated  ( )  Caco-2  cell  culture  supernatants.  All  metabolites  in  cell  culture 
supernatants were collected for each of control and DSS-treated cells at 10, 24, 32, and  
56 hours, and metabolites were measured, and averaged. Results therefore represent the 
mean of 16 determinations  SD, and * p < 0.00001. 
 
2.4. Discussion 
DSS is often used in animal studies to induce colitis [1,2]. However, the metabolic effects of DSS 
on intestinal epithelial cells have not been characterized to date. In this study, we applied 
1H NMR 
spectroscopy to study the effect of DSS on a cell-culture mimic of the human small intestine, Caco-2. 
Utilizing 1% DSS, we determined that cell viability was unaffected over 56 h, and that a 1.5-fold 
increase in IL-6 production by Caco-2 cells occurred upon incubation of Caco-2 cells with 1% DSS. 
This is in agreement to Araki et al. [10]. Furthermore, a significant decrease in alanine production was 
observed when Caco-2 cells were incubated with DSS, but no significant differences were observed in 
the concentrations of lactate or pyruvate. These observations suggest one of two mechanisms: either 
the  blocking  of  the  alanine  transporter,  or  the  inhibition  of  the  enzyme  alanine  aminotransferase 
(ALAT) either through blocking of transcription or blocking of the enzyme itself. 
Alanine  transport  in  Caco-2  cells  occurs  via  system  B,  which  is  a  sodium  dependent  
chloride-independent  transporter  that  also  transports  glutamine  [11].  If  DSS  were  blocking  this 
transporter,  changes  in  the  transport  of  glutamine  would  be  expected  (Figure  5).  However,  no 
significant  change  in  the  concentration  of  glutamine  was  observed  in  the  cell  supernatant  of  
DSS-treated  versus  control  cells.  Thus  the  lower  concentration  of  alanine  is  unlikely  due  to  the 
blockage of the alanine transporter. Although system B is a sodium-dependant transporter, it has been 
previously determined that sodium concentration does not affect maximal alanine influx [12,13]. Even Int. J. Mol. Sci. 2011, 12                       
 
 
2330 
so, the addition of 1% DSS to the cell culture only changed the conductivity by a small amount  
(16.7 mS/cm versus 15.4 mS/cm in the control media).  
Figure 5. Schematic of alanine metabolism in Caco-2 cells. Here it is shown that Caco-2 
cells absorb glucose, glutamine, and pyruvate from the medium and produce lactate and 
alanine  that  are  released.  Over  time,  glucose,  glutamine,  and  pyruvate  concentrations 
decrease in the medium while lactate and alanine concentrations increase.  
 
Alanine aminotranferase (ALAT) is an enzyme that catalyzes the transfer of the α-amino group 
from  glutamate  to  pyruvate  forming  alanine  and  α-ketoglutarate.  Inhibition  of  this  enzyme  would 
impact synthesis of alanine, but not necessarily change the concentration of other metabolites or affect 
other cellular pathways as pyruvate has many fates in the cell including the formation of lactate, other 
amino acids, and can enter the TCA cycle. α-Ketoglutarate can also enter the TCA cycle. If the reason 
for decreased alanine in the cell culture media is due to the inhibition of ALAT, it is likely that it 
occurs either through direct inhibition of the enzyme or through inhibition of transcription. In either 
case, the enzyme still functions as the concentration of alanine in the medium of DSS-treated cells 
does increase from the baseline level in the media over 56 hours. 
The fact that ALAT is somehow affected by DSS is an interesting finding. In a study involving 123 
IBD patients, it was determined that 49/50 CD patients had subnormal serum ALAT levels, whereas 
only  1/67  patients  with  UC  had  subnormal  ALAT  on  one  or  more  occasions  [14].  Interestingly, 
however, in a study of 544 patients, it was determined that ALAT was increased in concentration in 
the serum, with no specific association to IBD activity [15]. In another study, total enteral nutrition of 
pediatric patients was shown to be associated with a transient hypertransaminasemia and no other Int. J. Mol. Sci. 2011, 12                       
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evidence of liver disease [16]. In a study involving IL-10 gene deficient mice, it was determined that in 
both wild-type and gene-deficient mice, treatment of mice with dinitrobenzene sulfonic acid (DNBS) 
resulted  in  a  substantial  increase  in  serum  ALAT  [17].  However  serum  ALAT  did  not  appear 
significantly different from control in 5% DSS-treated mice [18]. Of importance, it was determined 
that  the  concentration  of  alanine  in  the  colonic  mucosa  of  patients  with  both  UC  and  CD  was 
decreased as compared to normals [19]. Moreover, alanine was shown to be significantly higher in 
fecal samples from CD patients, but not UC patients, as compared to control [20]. 
Taken together, regulation of ALAT activity, either through direct inhibition of the enzyme or 
inhibition  of  transcription,  has  an  association  with  inflammatory  bowel  disease,  and  in  particular 
Crohn’s disease. Whether it is directly related to the pathogenesis of CD, or is a consequence of the 
disease itself remains to be elucidated. The fact that in human patients serum ALAT deviations from 
normal may be transient in nature, and in most cases do not appear to be associated with liver disease 
suggests that there may be a dietary or bacterial flora connection. Although ALAT activity has often 
been thought of as an indicator of hepatic function, the increase in serum values of ALAT may be 
related  to  changes  in  the  intestinal  tissue  itself,  with  changes  in  intestinal  metabolism  potentially 
signaling changes in hepatic ALAT expression. Indeed it has been shown that patients with CD have 
increased insulin secretion [21], and that higher ALAT levels are associated with impaired glucose 
tolerance  [22].  Of  significance,  it  has  been  shown  that  p300  and  c-Myb  regulate  ALAT  gene 
transcription, and that insulin levels affect expression of these factors [23] thereby affecting ALAT 
gene  expression.  We  are  currently  investigating  whether  DSS  directly  inhibits  ALAT  or  inhibits 
transcription, and whether serum levels of ALAT can affect the action of DSS. 
3. Experimental Section 
3.1. Caco-2 Preparation and Reagents 
The  human  Caco-2  cell  line  has  been  widely  used  as  an  in  vitro  model  of  the  intestinal  
epithelium [24]. In this study, Caco-2 cells were obtained from American Tissue Culture Collection 
(ATCC, Manassas, VA, USA) at passage 18 and experiments were performed with cells from passages 
25–30.  Caco-2  cells  were  cultured  in  Dulbecco’s  modified  Eagle’s  minimum  essential  medium 
(DMEM, HyClone, Logan, UT, USA) supplemented with 25 mM glucose, 10% fetal bovine serum 
(FBS), 1% nonessential amino acids, 4 mM L-glutamine and 1% penicillin-streptomycin solution at  
37 ° C with 5% CO2. Dextran sulfate sodium (DSS, MW 36,000–50,000, MP Biomedicals LLC, Solon, 
OH, USA) was dissolved in culture media and filter-sterilized using a 0.2 m filter. To test the effect 
of DSS on Caco-2 cells, cells were seeded onto 24-well plates  (Costar, Corning, NY, USA) at a 
density of 1 ×  10
4 viable cells/cm
2. After 90–100% confluency, the Caco-2 cell monolayers were 
allowed to differentiate for an additional 14 days. Fully differentiated cell monolayers were incubated 
with or without 1% DSS in cell culture media for 2 to 56 h. The Caco-2 cells at different time points 
after DSS addition were observed under an Olympus IX71 inverted microscope equipped with a digital 
camera using MetaMorph software. Images of Caco-2 cells were taken at 40X magnification. 1.0 mL 
aliquots of supernatant samples were collected at different time points, centrifuged at 14,000 rpm for 
20 min to remove cellular debris, and stored at −80 °C until further analysis. Int. J. Mol. Sci. 2011, 12                       
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3.2. Caco-2 Cells Viability Test 
Caco-2 cells were incubated with DSS in 24 well plates as described above. At each time point,
 
cells were collected from the wells using 0.5 mL of 0.25% trypsin with 0.2 g/L
 EDTA (HyClone, 
Logan, UT, USA) and re-suspended in 1 mL of serum-free medium.
 The viability of control cells and 
cells incubated with DSS were determined using a Bright Line hemacytometer (Hausser Scientific, 
Horsham, PA, USA) and the trypan
 blue dye exclusion test. Results of viability are expressed as the 
percentage of the values obtained for control cells.  All experiments were performed four times. 
3.3. IL-6 Assay 
Caco-2 cells were incubated in 24-well plates (Costar) and cell culture supernatants were collected 
as  described  above.  IL-6  assays  were  performed  using  human  IL-6  ELISA  Ready-Set-Go  kit 
(eBioscience, Inc., San Diego, CA, USA) according to manufacturer instructions. 
3.4. NMR Sample Preparation, Spectroscopy and Analysis 
Sample preparation: Samples were prepared by thawing the frozen supernatant and filtering though 
a 3000 MW cutoff filter (Pall Life Sciences, Ann Arbor, MI, USA). 585 µ L of filtered sample was 
mixed  with  65  µL  of  Internal  Standard  (IS)  (5mM  DSS-d6  (3-(trimethylsilyl)-1-propanesulfonic  
acid-d6) with 0.2% NaN3, in 99.8% D2O and the pH was adjusted to 6.8 ±  0.1. A 600 L aliquot of 
each sample was transferred to a 5-mm NMR tube and stored at 4 ° C until NMR data acquisition. 
NMR spectroscopy: All one-dimensional NMR spectra of the samples were acquired using the first 
increment  of  the  standard  NOESY  pulse  sequence  on  a  Bruker  AVANCE  600  MHz  NMR 
spectrometer  equipped  with  a  SampleJet.  All  spectra  were  recorded  at  25  ° C  with  a  12  ppm 
sweepwidth,  2.5  s  recycle  delay,  100-ms  mix,  an  acquisition  time  of  2.5  s,  8  dummy  scans,  and  
32  transients. 
1H  saturation  of  the  water  resonance  was  applied  during  the  recycle  delay  and  the  
100  ms  mix.  All  spectra  were  zero-filled  to  128k  data  points  and  multiplied  by  an  exponential 
weighting function corresponding to a line-broadening of 0.5 Hz. 
Spectral analysis: Analysis of the NMR data was accomplished through targeted profiling using the 
Chenomx NMRSuite v6.1 (Chenomx Inc., Edmonton, Canada) [25]. A total of 39 metabolites were 
identified and quantified representing 99% of the spectral area. 
3.5. Statistical Analysis 
All data, including the concentrations derived from the 
1H NMR spectra, IL-6 ELISA results, and 
viability of Caco-2 cells, are presented as mean ±  SD. The difference in levels of variable between 
treatment and control were evaluated for individual values using the Student’s t-test. P-values of <0.05 
were considered to be statistically significant. Int. J. Mol. Sci. 2011, 12                       
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4. Conclusions 
The goal of this study was to understand the effect of DSS on Caco-2 cell metabolism. Although 
cell viability was similar, and IL-6 production was increased approximately 1.5 times, the only major 
metabolite difference observed when Caco-2 cells were incubated with 1% DSS was a decrease in 
alanine concentration in the cell culture medium as compared with controls. Since the concentration of 
glutamine and other amino acids were unaffected, we ruled out the possibility that DSS inhibited 
alanine  transport  across  the  membrane.  These  results  suggest  that  either  transcription  of  alanine 
aminotransferase is inhibited, or the enzyme itself is inhibited. This study emphasizes that alanine 
aminotransferase has a direct relationship with inflammatory bowel disease, and in particular CD, and 
may provide a more thorough understanding of the pathogenesis of CD in addition to the metabolic 
mechanisms for DSS-induced colitis in animal models. Work is currently under way to determine how 
alanine aminotransferase is inhibited by DSS. 
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